[Rehabilitation in Tay-Sachs disease: A case report]

Rehabilitacion (Madr). 2022 Apr-Jun;56(2):164-167. doi: 10.1016/j.rh.2020.10.010. Epub 2021 Apr 6.
[Article in Spanish]

Abstract

Tay-Sachs disease, or GM2 gangliosidosis, is a congenital and neurodegenerative disease caused by the absence or deficiency of the essential enzyme B-hexosaminidase. The timing of the development of neurological manifestations and their severity depend on the mutation, time since disease onset and the patient's characteristics. The disease impairs quality of life and increases mortality. In the most aggressive forms, life expectancy is 3 years. Despite various clinical trials and ongoing research, there is currently no cure for Tay-Sachs disease. Treatment focuses on symptom control and ensuring greater patient wellbeing. Consequently, rehabilitation plays a fundamental role in the management of these patients and in enhancing their quality of life.

Keywords: GM2 Gangliosidosis; Gangliosidosis GM2; Rehabilitación; Rehabilitation; Tay-Sachs.

Publication types

  • Case Reports

MeSH terms

  • Humans
  • Mutation
  • Neurodegenerative Diseases*
  • Quality of Life
  • Tay-Sachs Disease* / genetics
  • beta-N-Acetylhexosaminidases / genetics

Substances

  • beta-N-Acetylhexosaminidases